James Hall
Director Ejecutivo en Betagenon Sweden AB .
Cargos activos de James Hall
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Director Ejecutivo | 27/05/2021 | - |
Historial de carrera de James Hall
Formación de James Hall.
| University of Oxford | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 2 |
| Reino Unido | 2 |
Operativa
| Chief Executive Officer | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- James Hall
- Experiencia
